SCRI-Nashville — Nashville, Tennessee

SCRI-Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

SCRI-Nashville has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Solid Tumors, Non-Small Cell Lung Cancer, Advanced Solid Malignancies.

Sponsors: Quanta Therapeutics, Summit Therapeutics, Treadwell Therapeutics, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI-Nashville?

SCRI-Nashville has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI-Nashville conducted?

SCRI-Nashville has 4 clinical trials on record, with 4 currently active. Their work covers Solid Tumors, Non-Small Cell Lung Cancer, Advanced Solid Malignancies.

Is SCRI-Nashville accredited by Crixeo Clinical Trials?

SCRI-Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI-Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.